Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Other Non-Current Assets: 2010-2025

Historic Other Non-Current Assets for Ironwood Pharmaceuticals (IRWD) over the last 15 years, with Sep 2025 value amounting to $4.8 million.

  • Ironwood Pharmaceuticals' Other Non-Current Assets fell 22.93% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 22.93%. This contributed to the annual value of $5.9 million for FY2024, which is 64.16% up from last year.
  • Ironwood Pharmaceuticals' Other Non-Current Assets amounted to $4.8 million in Q3 2025, which was down 5.96% from $5.2 million recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Other Non-Current Assets ranged from a high of $6.3 million in Q3 2024 and a low of $820,000 during Q1 2023.
  • In the last 3 years, Ironwood Pharmaceuticals' Other Non-Current Assets had a median value of $4.3 million in 2024 and averaged $4.3 million.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Other Non-Current Assets skyrocketed by 349.54% in 2023 and then decreased by 22.93% in 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Other Non-Current Assets (Quarterly) stood at $1.0 million in 2021, then decreased by 15.30% to $847,000 in 2022, then soared by 325.97% to $3.6 million in 2023, then skyrocketed by 64.16% to $5.9 million in 2024, then dropped by 22.93% to $4.8 million in 2025.
  • Its Other Non-Current Assets was $4.8 million in Q3 2025, compared to $5.2 million in Q2 2025 and $5.5 million in Q1 2025.